2012 ACCP Annual Meeting: Poster Presentations III

440

A hospital's effort to lower the readmission of patients with heart failure (help-hf): a pilot study

Pamela M. Moye, PharmD, BCPS¹, Paul Douglass, MD², Phillip S. Owen, PharmD, BCPS¹ and Teresa Pounds, PharmD, BCNSP²
1Mercer University College of Pharmacy and Health Sciences, Atlanta, GA
2Atlanta Medical Center, Atlanta, GA

441

Prescribing patterns for the outpatient treatment of constipation, irritable bowel syndrome-related constipation and opioid-induced constipation

Katy E. Trinkley, PharmD¹, Bruce Sill, PharmD, MS², Kyle Porter, MAS³ and Milap C. Nahata, PharmD, MS⁴
1University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO
2Takeda Pharmaceuticals International, Inc., Glastonbury, CT
3Ohio State University Center for Biostatistics, Columbus, OH
4Ohio State University College of Pharmacy, Columbus, OH

442

A retrospective chart review of the standard of asthma care in a primary care teaching clinic

Lindsay A. Sorge, PharmD and Chrystian R. Pereira, Pharm.D.
University of Minnesota College of Pharmacy, Minneapolis, MN

443

Effects on warfarin dosage requirements after anticoagulation therapy with dabigatran

Beth H. Brubaker, PharmD, Kristy Lucas, PharmD and Mike Broce, BA
University of Charleston School of Pharmacy, Charleston, WV

444

Impact of Medicare Part D on Community Pharmacy: A multi-region, multi-state survey

Shamima Khan, MBA, PhD
Western New England University, Springfield, MA

445

Evaluation of a lecture on hospice care for PharmD students

Cara L. McDermott, PharmD, MS and Dana P Hammer, RPh, PhD
University of Washington School of Pharmacy, Seattle, WA

446E

Impact of a Student Pharmacist Driven Medication History Service

Lynette R. Moser, Pharm.D.¹, Justine S. Gortney, PharmD¹, Josh Raub, PharmD² and Kim Claeys, PharmD¹
1Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI
2Detroit Receiving Hospital / University Health Center, Detroit, MI

447

Outcomes associated with emergency department pharmacists' participation in antimicrobial stewardship

Stephanie Z. Kujawski, PharmD¹ and Bethany S. Delk, Pharm.D., BCPS²
1Mission Hospitals, Asheville, NC
2Department of Pharmacy, Mission Health System, Asheville, NC

448

Cancer Adverse Events Associated with Dipeptidyl Peptidase 4 Inhibitors: Data Mining of Public FDA Adverse Event Reporting System

Xiaodong Feng, PhD, PharmD, Amie Cai, B.S., Kevin Dong, PharmD Student, Nilesh Bhutada, PhD and John Inciardi, PharmD, D.Sci.
California Northstate University College of Pharmacy, Rancho Cordova, CA

449

Modeling and Simulation to Predict the Pharmacokinetics of Intravenous Cefazolin in Children – A Strategy to Reduce the Number of Pediatric Subjects in Pharmacokinetic Studies

Felix Siegel, PhD¹, Christopher M. Rubino, Pharm.D., BCPS², Rebecca A. Stolarick, BS¹, Patricia A. Smith, BS¹ and Martin Unverdorben, MD, PhD¹
1B. Braun Medical Inc., Allentown, PA
2Institute for Clinical Pharmacodynamics, Latham, NY

450

Increasing Medication Core Measures Compliance Utilizing Unit-Based Clinical Pharmacists

Lindsay I. Varga, Pharm.D., BCPS, Elizabeth Marino Sabo, Pharm.D., BCPS, Jacqueline M. von Vital, Pharm.D. and Suzanne Y. Brown, M.S., RPh
Pennsylvania Hospital, Philadelphia, PA

Impact of an evidence-based pharmacotherapy elective on performance during the fourth-professional year

Nathan Pinner, Pharm.D., BCPS¹ and Jessica Starr, PharmD, BCPS²
1Auburn University Harrison School of Pharmacy, Tuscaloosa, AL
2Auburn University Harrison School of Pharmacy, Birmingham, AL

Comparison of serum cystatin c versus serum creatinine in predicting vancomycin trough levels in patients with reduced muscle mass

Douglas D. DeCarolis, Pharm, D¹, Joey Thorson, PharmD², Rebecca Marraffa, PharmD³ and Megan A. Clairmont, PharmD⁴
1Minneapolis VA Medical Center, Minneapolis, MN
2Minneapolis Veterans Affair Medical Center, Minneapolis, MN
3Memorial Hermann - Pharmacy Wellness Clinic, Houston, TX
4Minneapolis Veteran Affairs Health Care System, Minneapolis, MN

Impact of antibiotic selection on risk-adjusted mortality in ICU patients requiring gram-negative therapy

John S. Esterly, Pharm.D.¹, Jean A. Patel, Pharm.D.², Milena McLaughlin, Pharm.D.³, Curtis H. Weiss, M.D, M.S.⁴, Richard G. Wunderink, M.D.⁴, Kristin March, Pharm.D.², Craig Cooper, Pharm.D.⁴, Erik Rachwalski, Pharm.D. ⁴ and Michael J. Postelnick, B.Pharm⁴
1Chicago State University College of Pharmacy, Chicago, IL
2Northwestern Memorial Hospital, Chicago, IL
3Midwestern University Chicago College of Pharmacy, Downers Grove, IL
4Northwestern University Feinberg School of Medicine, Chicago, IL

Adequacy of empiric coverage for Gram-negative bacteremias in an adult population

Branden Nemecek, PharmD, Nicole Bohm, PharmD and Juanmanuel Gomez, MD
Medical University of South Carolina, Charleston, SC

Economic evaluation of the impact of medication errors

Jennifer Samp, PharmD¹, Daniel R. Touchette, Pharm.D., M.A.², Jacqueline S. Marinac, Pharm.D.³ and Grace M. Kuo, PharmD, MPH, PhD⁴
1University of Illinois, Chicago, IL
2University of Illinois at Chicago, Chicago, IL
3ACCP Research Institute, Lenexa, KS
4UCSD, La Jolla, CA